BioNTech (BNTX) PT Lowered to $300 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Arlinda Lee lowered the price target on BioNTech (NASDAQ: BNTX) to $300.00 (from $450.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
